Researchmoz added Most up-to-date research on "Global Radiofrequency Ablation Market Forecasted To Grow At A CAGR Of 8.78% Between The Period 2017 - 2021" to its huge collection of research reports.
Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic waves to generate heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, and remove or trim obstructive tissues and dead nerves. The process is carried out by inserting a special needle through the skin onto the tumor. The procedure targets specific tissue/nerve with radiofrequency electrical energy, heating the tumor through an active exposed electrode tip.
Technavios analysts forecast the global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global radiofrequency ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of equipment and accessories used in radiofrequency ablation.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AngioDynamics
Boston Scientific
Medtronic
St. Jude Medical
Stryker
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1063480
Other prominent vendors
Accuray
Advanced Cardiac Therapeutics
APT Medical
Arthrex
AtriCure
Biosense Webster
BIOTRONIK
Bovie Medical
CardioFocus
CONMED
DVx
Hansen Medical
Halyard Health
Imricor Medical Systems
Japan Lifeline
Merit Medical Systems
MicroPort Scientific
Osypka Medical
PLC Medical Systems
RF Medical
Smith & Nephew
Spacelabs Healthcare
Spectranetics
Theraclion
Total Vein Systems
Market driver
Increasing incidence of chronic disorders and growing older population
For a full, detailed list, view our report
Market challenge
Risks and complications associated with radiofrequency ablation
For a full, detailed list, view our report
Browse TOC @ https://www.researchmoz.us/global-radiofrequency-ablation-market-2017-2021-report.html/toc
Market trend
New product launches coupled with R&D activities
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic waves to generate heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, and remove or trim obstructive tissues and dead nerves. The process is carried out by inserting a special needle through the skin onto the tumor. The procedure targets specific tissue/nerve with radiofrequency electrical energy, heating the tumor through an active exposed electrode tip.
Technavios analysts forecast the global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global radiofrequency ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of equipment and accessories used in radiofrequency ablation.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AngioDynamics
Boston Scientific
Medtronic
St. Jude Medical
Stryker
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1063480
Other prominent vendors
Accuray
Advanced Cardiac Therapeutics
APT Medical
Arthrex
AtriCure
Biosense Webster
BIOTRONIK
Bovie Medical
CardioFocus
CONMED
DVx
Hansen Medical
Halyard Health
Imricor Medical Systems
Japan Lifeline
Merit Medical Systems
MicroPort Scientific
Osypka Medical
PLC Medical Systems
RF Medical
Smith & Nephew
Spacelabs Healthcare
Spectranetics
Theraclion
Total Vein Systems
Market driver
Increasing incidence of chronic disorders and growing older population
For a full, detailed list, view our report
Market challenge
Risks and complications associated with radiofrequency ablation
For a full, detailed list, view our report
Browse TOC @ https://www.researchmoz.us/global-radiofrequency-ablation-market-2017-2021-report.html/toc
Market trend
New product launches coupled with R&D activities
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
No comments:
Post a Comment